Literature DB >> 25911942

[Secondary cancers: Incidence, risk factors and recommendations].

Charlotte Demoor-Goldschmidt1, Chiraz Fayech2, Pauline Girard3, Dominique Plantaz3.   

Abstract

Cure rates for most childhood cancers and adolescents have made remarkable progress over the last thirty to forty years. The development of secondary malignancies has become an important question for these patients. The frequency is low, but the risk is significantly higher (between 3 and 10 times) and it is the leading cause of long-term mortality off relapse. In this literature review, we discuss the epidemiological aspect and the risk factors contributing to this increased risk, and conclude with a summary of current recommendations for screening and surveillance. We also discuss briefly the constitutional predisposing genetic contributions to other cancers.
Copyright © 2015 Société Française du Cancer. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Breast; Cancer pédiatrique; Cancers secondaires; Pediatric cancer; Recommandation; Recommendation; Secondary cancers; Sein; Survivant; Survivor; Thyroid; Thyroïde

Mesh:

Substances:

Year:  2015        PMID: 25911942     DOI: 10.1016/j.bulcan.2015.03.011

Source DB:  PubMed          Journal:  Bull Cancer        ISSN: 0007-4551            Impact factor:   1.276


  3 in total

Review 1.  Review of risk factors of secondary cancers among cancer survivors.

Authors:  Charlotte Demoor-Goldschmidt; Florent de Vathaire
Journal:  Br J Radiol       Date:  2018-09-12       Impact factor: 3.039

2.  A French national breast and thyroid cancer screening programme for survivors of childhood, adolescent and young adult (CAYA) cancers - DeNaCaPST programme.

Authors:  Charlotte Demoor-Goldschmidt; Delphine Drui; Isabelle Doutriaux; Gérard Michel; Pascal Auquier; Agnès Dumas; Claire Berger; Valérie Bernier; Sandrine Bohrer; Pierre-Yves Bondiau; Bruno Filhon; Brice Fresneau; Claire Freycon; Dinu Stefan; Sylvie Helfre; Angela Jackson; Christine Kerr; Anne Laprie; Julie Leseur; Marc-André Mahé; Caroline Oudot; Claire Pluchard; Stéphanie Proust; Hélène Sudour-Bonnange; Céline Vigneron; Nathalie Lassau; Martin Schlumberger; Cécile Faure Conter; Florent de Vathaire
Journal:  BMC Cancer       Date:  2017-05-12       Impact factor: 4.430

Review 3.  Metastatic and triple-negative breast cancer: challenges and treatment options.

Authors:  Sumayah Al-Mahmood; Justin Sapiezynski; Olga B Garbuzenko; Tamara Minko
Journal:  Drug Deliv Transl Res       Date:  2018-10       Impact factor: 4.617

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.